According to a new report, published by KBV research, The Global Adhesion Barrier Market size is expected to reach $1.2 billion by 2030, rising at a market growth of 7.2% CAGR during the forecast period.
The General/Abdominal Surgeries segment is leading the Global Adhesion Barrier Market by Application Area in 2022; thereby, achieving a market value of $261.2 million by 2030. The scar tissue that develops between the abdominal organs and tissues is known as abdominal adhesion, and it causes the organs and tissues to stay together. Following abdominal surgery, adhesions may cause tissues to stick together when typically, they would just move around freely.
The Liquid Formulations segment would showcase a CAGR of 7.6% during (2023 - 2030). During surgical procedures, liquid adhesion barriers are administered as sprays or irrigants. They are used to coat the tissues and form a physical barrier, thereby preventing the formation of adhesions. Liquid formulations are particularly useful in procedures where the direct application of a film or substance would be difficult or impractical.
The Synthetic Products segment is generating the highest revenue in the Global Adhesion Barrier Market by Product in 2022; thereby achieving a market value of $724.1 million by 2030. The cost-effectiveness of synthetic adhesion barriers is anticipated to boost segment sales. In addition, the segment's dominance is predominantly attributable to the commercial availability of synthetic adhesion barriers. Postoperative complications such as adhesions can prolong hospital stays, lead to the need for additional surgeries, and increase recovery times.
The Ambulatory Surgical Centers segment is exhibiting a CAGR of 7.7% during (2023 - 2030). Numerous ASCs specialize in minimally invasive procedures that still pose the risk of adhesion formation owing to tissue manipulation. Although these procedures typically involve minor incisions, using instruments and gas insufflation can lead to the formation of adhesions. Adhesion barriers can reduce this risk.
The North America region dominated the Global Adhesion Barrier Market by Region in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $402.4 million by 2030. The Europe market is anticipated to grow at a CAGR of 7% during (2023 - 2030). Additionally, The Asia Pacific market would witness a CAGR of 7.9% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/adhesion-barrier-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Sanofi S.A., Becton Dickinson and Company, Baxter International, Inc. (Hill-Rom Holdings, Inc.), Johnson & Johnson, Anika Therapeutic, Inc., FzioMed, Inc., MAST Biosurgery USA, Inc. (MAST Biosurgery AG), Innocoll Biotherapeutics N.A. Inc., Luna Innovations, Incorporated and Integra LifeSciences Holdings Corporation.
By Application Area
By Formulation
By Product
By End User
By Geography
Companies Profiled
Unique Offerings 
